You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

CX-072

Showing 1 - 25 of 93
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Solid Tumor, Lymphoma Trial in Worldwide (CX-072, ipilimumab, vemurafenib)

Completed
  • Solid Tumor
  • Lymphoma
  • CX-072
  • +2 more
  • Los Angeles, California
  • +30 more
Feb 7, 2022

Tumors, Breast Tumors, Breast Tumors, Triple-Negative Trial in Korea, Republic of, Spain, United States (CX-2009, CX-072)

Active, not recruiting
  • Neoplasms
  • +4 more
  • La Jolla, California
  • +41 more
Aug 5, 2022

Solid Tumor, Unresectable or Metastatic Melanoma Trial in Worldwide (CX-072, Ipilimumab)

Terminated
Has Results
  • Solid Tumor
  • Unresectable or Metastatic Melanoma
  • Duarte, California
  • +26 more
Nov 2, 2021

Breast Cancer Metastatic Trial in Worldwide (MCLA-128, Trastuzumab, Vinorelbine)

Active, not recruiting
  • Breast Cancer Metastatic
  • Los Angeles, California
  • +24 more
Aug 10, 2022

Selected Advanced Solid Tumors Trial in Worldwide (MEDI5752, Pemetrexed, Carboplatin)

Recruiting
  • Selected Advanced Solid Tumors
  • MEDI5752
  • +4 more
  • Detroit, Michigan
  • +40 more
Oct 31, 2022

Validation of the European Oncology Quality of Life Toolkit

Not yet recruiting
  • Cancer
  • +2 more
  • Administration of the EUonQoL-Kit - Active Treatment questionnaire
  • +2 more
  • Tirana, Albania
  • +44 more
Jul 17, 2023

Advanced NSCLC, EGFR Mutation, HER2 Mutation Trial in Worldwide (BAY2927088_formulation A, BAY2927088_formulation B_1,

Recruiting
  • Advanced Non-small Cell Lung Cancer
  • +2 more
  • BAY2927088_formulation A
  • +2 more
  • Gilbert, Arizona
  • +75 more
Jan 16, 2023

Leukemia, Myeloid, Acute Trial in Worldwide (AG-120, Azacitidine, AG-221)

Active, not recruiting
  • Leukemia, Myeloid, Acute
  • Duarte, California
  • +72 more
Aug 18, 2022

Head Neck Cancer Trial (Retifanlimab, INCAGN02385, INCAGN02390)

Recruiting
  • Head and Neck Cancer
  • Scottsdale, Arizona
  • +87 more
Dec 12, 2022

Solid Tumor, Adult, Head Neck Cancer, Non Small Cell Lung Cancer Trial in Worldwide (CX-2029)

Active, not recruiting
  • Solid Tumor, Adult
  • +4 more
  • Birmingham, Alabama
  • +24 more
Aug 5, 2022

Melanoma Trial in Worldwide (Talimogene Laherparepvec, Pembrolizumab, Placebo)

Terminated
Has Results
  • Melanoma
  • Talimogene Laherparepvec
  • +2 more
  • Birmingham, Alabama
  • +160 more
Nov 10, 2022

Carcinoma, Basal Cell Trial in United States (CX-4945)

Recruiting
  • Carcinoma, Basal Cell
  • Aurora, Colorado
  • +3 more
Mar 11, 2022

COVID-19 Trial in Taipei (CX-4945)

Active, not recruiting
  • COVID-19
  • Taipei, Taiwan
    Taipei Medical University Hospital
Apr 16, 2023

Nonsquamous NSCLC, EGFR L858R, EGFR Exon 19 Deletion Trial in Worldwide (Patritumab Deruxtecan, Platinum-based chemo)

Recruiting
  • Nonsquamous Non-small Cell Lung Cancer
  • +2 more
  • Patritumab Deruxtecan
  • Platinum-based chemotherapy
  • Anchorage, Alaska
  • +182 more
Jan 17, 2023

Solid Tumors Trial in Nashville (CX-904)

Recruiting
  • Solid Tumors
  • Nashville, Tennessee
    Sarah Cannon Research Institute, LLC
May 19, 2022

Ovarian Cancer Trial in Worldwide (Bevacizumab, liposomal doxorubicin, paclitaxel)

Completed
Has Results
  • Ovarian Cancer
  • Bruxelles, Belgium
  • +116 more
May 5, 2022

Triple Negative Breast Cancer, TNBC - Triple-Negative Breast Cancer Trial in United States (Paclitaxel, CB-839)

Completed
Has Results
  • Triple Negative Breast Cancer
  • TNBC - Triple-Negative Breast Cancer
  • Birmingham, Alabama
  • +24 more
Sep 19, 2022

Urinary Bladder Tumors, Muscle-Invasive Bladder Cancer Trial in Worldwide (Nivolumab, Gemcitabine, Cisplatin)

Active, not recruiting
  • Urinary Bladder Neoplasms
  • Muscle-Invasive Bladder Cancer
  • Nivolumab
  • +2 more
  • Tucson, Arizona
  • +172 more
Jan 25, 2023

Cholangiocarcinoma Trial in Korea, Republic of, Taiwan, United States (CX-4945, Cisplatin, Gemcitabine)

Completed
  • Cholangiocarcinoma
  • Scottsdale, Arizona
  • +15 more
Oct 20, 2021

Non-GCB/ABC DLBCL, With and Without MyD88 and/or CD79B Mutations Trial in Cleveland, Toledo (Mivavotinib)

Recruiting
  • Non-GCB/ABC Diffuse Large B-Cell Lymphoma
  • With and Without MyD88 and/or CD79B Mutations
  • Evanston, Illinois
  • +6 more
Dec 12, 2022

Cancer of Unknown Primary Site Trial in Worldwide (Alectinib, Vismodegib, Ipatasertib)

Active, not recruiting
  • Cancer of Unknown Primary Site
  • Blacktown, New South Wales, Australia
  • +140 more
Jan 6, 2023

Solid Tumor, Adult Trial in Fairfax (CX-188)

Withdrawn
  • Solid Tumor, Adult
  • Fairfax, Virginia
    Virginia Cancer Specialists
Apr 30, 2021

Advanced Breast Cancer Trial in Worldwide (Ribociclib, fulvestrant, Ribociclib )

Active, not recruiting
Has Results
  • Advanced Breast Cancer
  • Mobile, Alabama
  • +173 more
Aug 4, 2022

Calcified Atheroma Trial (Electrohydraulic shock wave lithotripsy, Rotary atherectomy)

Not yet recruiting
  • Calcified Atheroma
  • Electrohydraulic shock wave lithotripsy
  • Rotary atherectomy
  • (no location specified)
Feb 7, 2023

Urinary Bladder Tumors Trial in Worldwide (TAR-200, Cetrelimab)

Recruiting
  • Urinary Bladder Neoplasms
  • Phoenix, Arizona
  • +183 more
Jan 27, 2023